Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: J Clin Psychopharmacol. 2017 Apr;37(2):269–271. doi: 10.1097/JCP.0000000000000659

Figure 1.

Figure 1

Change in OCD [Yale-Brown Obsessive-Compulsive Scale (YBOCS)] and MDD [Montgomery-Asberg Depression Rating Scale (MADRS)] severity (right axis) were modest following ketamine and CBT (shaded area) but suicidality (MADRS item 10, left axis) drastically reduced following the first week of ketamine treatment.